Sangamo Biosciences competitive analysis

Explore Sangamo Biosciences's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 3, 2026
Patent NumberPublication DateTitleTotal Oppositions
Oct 13, 2021Methods And Compositions For Inactivating Alpha 1,6 Fucosyltransferase (Fut 8) Gene Expression1
Oct 17, 2018Methods And Compositions For The Treatment Of Monogenic Diseases3
Aug 27, 2014Methods And Compositions For Inactivating Alpha 1,6 Fucosyltransferase (Fut 8) Gene Expression1

Latest PTAB cases involving Sangamo Biosciences

Discover the latest PTAB cases involving Sangamo Biosciences, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Sangamo Biosciences with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 3, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SANGAMO BIOSCIENCES - 5 - -
LEEMING25 - - -
LONZA44 - -
MATHYS & SQUIRE61 - - -